Journal of Hepatology
Volume 53, Issue 2 , Pages 291-297 , August 2010

Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival

  • Valentina Santi

      Affiliations

    • Dipartimento di Medicina Clinica, Unità di Semeiotica Medica, Alma Mater Studiorum – Università di Bologna, Italy
  • ,
  • Franco Trevisani

      Affiliations

    • Dipartimento di Medicina Clinica, Unità di Semeiotica Medica, Alma Mater Studiorum – Università di Bologna, Italy
    • Corresponding Author InformationCorresponding author. Address: Dipartimento di Medicina Clinica, Semeiotica Medica, via Albertoni, 15, 40138 Bologna, Italy. Tel.: +39 051 6362923; fax: +39 051 6362930.
  • ,
  • Annagiulia Gramenzi

      Affiliations

    • Dipartimento di Medicina Clinica, Unità di Semeiotica Medica, Alma Mater Studiorum – Università di Bologna, Italy
  • ,
  • Alice Grignaschi

      Affiliations

    • Dipartimento di Medicina Clinica, Unità di Semeiotica Medica, Alma Mater Studiorum – Università di Bologna, Italy
  • ,
  • Federica Mirici-Cappa

      Affiliations

    • Dipartimento di Medicina Clinica, Unità di Semeiotica Medica, Alma Mater Studiorum – Università di Bologna, Italy
  • ,
  • Paolo Del Poggio

      Affiliations

    • Divisione di Medicina, Ospedale Treviglio-Caravaggio, Treviglio, Italy
  • ,
  • Maria Anna Di Nolfo

      Affiliations

    • Divisione di Medicina, Azienda Ospedaliera Bolognini, Seriate, Italy
  • ,
  • Luisa Benvegnù

      Affiliations

    • Dipartimento di Medicina Clinica e Sperimentale, Unità di Medicina, Università di Padova, Italy
  • ,
  • Fabio Farinati

      Affiliations

    • Dipartimento di Scienze Chirurgiche e Gastroenterologiche, Unità di Gastroenterologia, Università di Padova, Italy
  • ,
  • Marco Zoli

      Affiliations

    • Dipartimento di Medicina Clinica, Unità di Medicina, Alma Mater Studiorum – Università di Bologna, Italy
  • ,
  • Edoardo Giovanni Giannini

      Affiliations

    • Dipartimento di Medicina Interna, Unità di Gastroenterologia, Università di Genova, Italy
  • ,
  • Franco Borzio

      Affiliations

    • Dipartimento di Medicina, Unità di Medicina Interna ed Epatologia, Ospedale Fatebenefratelli, Milano, Italy
  • ,
  • Eugenio Caturelli

      Affiliations

    • Unità di Gastroenterologia, Ospedale Belcolle, Viterbo, Italy
  • ,
  • Maria Chiaramonte

      Affiliations

    • Unità di Gastroenterologia, Ospedale Sacro Cuore Don Calabria, Negrar, Italy
  • ,
  • Mauro Bernardi

      Affiliations

    • Dipartimento di Medicina Clinica, Unità di Semeiotica Medica, Alma Mater Studiorum – Università di Bologna, Italy
  • ,
  • for the Italian Liver Cancer (ITA.LI.CA) Group

      Affiliations

    • Other members of the ITA.LI.CA group: Dipartimento di Medicina Clinica, Alma Mater Studiorum – Università di Bologna, Italia: Pietro Andreone, Paolo Caraceni, Antonio Di Micoli, Marco Domenicali, Gianluca Fatti, Donatella Magalotti, Andrea Zambruni; Divisione di Medicina, Azienda Ospedaliera Bolognini, Seriate, Italia: Claudia Balsamo, Maria Di Marco, Elena Vavassori; Divisione di Medicina, Ospedale Treviglio-Caravaggio, Treviglio, Italia: Lodovico Gilardoni, Mario Mattiello; Dipartimento di Medicina Clinica e Sperimentale, Università di Padova, Italia: Alfredo Alberti, Angelo Gatta, Maurizio Gios; Dipartimento di Scienze Chirurgiche e Gastroenterologiche, Università di Padova, Italia: Massimo De Giorgio, Anna Giacomin, Simona Gianni, Michela Rinaldi, Adriana Sergio, Veronica Vanin; Dipartimento di Discipline Chirurgiche, Rianimatorie e dei Trapianti, Alma Mater Studiorum – Università di Bologna, Italia: Gian Luca Grazi, Antonio Daniele Pinna, Matteo Ravaioli; Dipartimento di Malattie Apparato Digerente e Medicina Interna, Azienda ospedaliero-universitaria di Bologna, Italia: Emanuela Giampalma, Rita Golfieri; Unità di Gastroenterologia, Ospedale Belcolle, Viterbo, Italia: Giorgia Ghittoni, Paola Roselli; Dipartimento di Medicina Interna, Unità di Gastroenterologia, Italia, Università di Genova: Giorgia Bodini, Marina Corbo, Vincenzo Savarino.

Received 21 December 2009 ,Revised 12 March 2010 ,Accepted 16 March 2010.

References 

  1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics 2002. CA Cancer J Clin. 2005;55:74–108
  2. Sangiovanni A, Del Ninno E, Fasani P, De Fazio C, Ronchi G, Romeo R, et al. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology. 2004;126:1005–1014
  3. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907–1917
  4. Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004;127:S35–S50
  5. Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med. 1993;328:1797–1801
  6. Kiyosawa K, Unemura T, Ichijo T, Matsumoto A, Yoshizawa K, Gad A, et al. Hepatocellular carcinoma: recent trends in Japan. Gastroenterology. 2004;127:S17–S26
  7. Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol. 2004;127:35–50
  8. Yuen MF, Cheng CC, Lauder IJ, Lam SK, Ooi CG, Lai CL. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology. 2000;31:330–335
  9. Bolondi L, Sofia S, Siringo S, Gaiani S, Casali A, Zironi G, et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost-effectiveness analysis. Gut. 2001;48:251–259
  10. Trevisani F, De Notariis S, Rapaccini G, Farinati F, Benvegnù L, Zoli M, et al. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience). Am J Gastroenterol. 2002;97:734–744
  11. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol. 2001;35:421–430
  12. Bruix J, Sherman M. Practice Guidelines Committee, American Association for the Study of the Liver Diseases. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208–1236
  13. Llovet JM, Bruix J. Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol. 2008;48:S20–S37
  14. Kojiro M, Roskams T. Early hepatocellular carcinoma and dysplastic nodules. Semin Liver Dis. 2005;25:133–142
  15. Ikai I, Arii S, Kojiro M, Ichida T, Makuuchi M, Matsuyama Y, et al. Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer. 2004;101:796–802
  16. Huang GT, Lee PH, Tsang YM, Lai MY, Yang PM, Hu RH, et al. Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma. A prospective study. Ann Surg. 2005;242:36–42
  17. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3cm or less. Gut. 2005;54:1151–1156
  18. Lencioni RA, Allgaier HP, Cioni D, Olschewski M, Deibert P, Crocetti L, et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology. 2003;228:235–240
  19. Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impact on long-term survival. Ann Surg. 2007;245:51–58
  20. Fasani P, Sangiovanni A, De Fazio C, Borzio M, Bruno S, Ronchi G, et al. High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors. Hepatology. 1999;29:1704–1707
  21. Trevisani F, Magini G, Santi V, Morselli-Labate AM, Cantarini MC, Di Nolfo MA, et al. Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance. Am J Gastroenterol. 2007;102:1022–1231
  22. Trevisani F, Santi V, Gramenzi A, Di Nolfo MA, Del Poggio P, Benvegnù L, et al. Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis?. Am J Gastroenterol. 2007;102:2448–2457
  23. Pascual S, Irurzun J, Zapater P, Such J, Sempere L, Carnicer F, et al. Usefulness of surveillance programmes for early diagnosis of hepatocellular carcinoma in clinical practice. Liver Int. 2008;28:682–689
  24. Kim DY, Han KH, Ahn SA, Pik YH, Lee KS, Chon CY, et al. Semiannual surveillance for hepatocellular carcinoma improved patient survival compared to annual surveillance (Korean experience). Hepatology. 2007;46(Suppl.):403A;[abstract]
  25. Commissione “Epatocarcinoma” dell’Associazione Italiana per lo Studio del Fegato. Epatocarcinoma: Linee Guida per la Diagnosi e la Terapia. Bologna: Tipografia Moderna; 1998.
  26. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis. N Engl J Med. 1996;334:693–699
  27. Adams PC, Arthur MJ, Boyer TD, DeLeve LD, Di Bisceglie AM, Hall M, et al. Screening in liver disease: report of an AASLD clinical workshop. Hepatology. 2004;39:1204–1212
  28. Schwartz MA. Biomathematical approach to clinical tumor growth. Cancer. 1961;14:1272–1294
  29. Scheu JC, Sung JL, Chen DS, Yang PM, Lai MY, Lee CS, et al. Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology. 1985;89:259–266
  30. Chalasani N, Horlander JC, Said A, Hoen H, Kopecky KK, Stockberger SM, et al. Screening for hepatocellular carcinoma in patients with advanced cirrhosis. Am J Gastroenterol. 1999;94:2988–2993
  31. Sarasin FP, Giostra E, Hadengue A. Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis. Am J Med. 1996;101:422–434
  32. Andersson KL, Salomon JA, Goldie SJ, Chung RT. Cost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol. 2008;6:1418–1424
  33. Trinchet J, Beaugrand M, for GRETCH. A randomised trial comparing 3-month vs. 6-month screening for HCC by ultrasonography in cirrhosis [abstract]. Book of Abstract-International Liver Cancer Association (ILCA), 2007.
  34. Ando E, Kuromatsu R, Tanaka M, Takada A, Fukushima N, Sumia S, et al. Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease. J Clin Gastroenterol. 2006;40:942–948
  35. Tanaka H, Nouso K, Kobashi H, Kobayashi Y, Nakamura S, Miyake Y, et al. Surveillance of hepatocellular carcinoma in patients with hepatitis C virus infection may improve patient survival. Liver Int. 2006;26:543–551
  36. Nouso K, Tanaka H, Uematsu S, Shiraga K, Okamoto R, Onishi H, et al. Cost-effectiveness of the surveillance program of hepatocellular carcinoma depends on the medical circumstances. J Gastroenterol Hepatol. 2008;23:437–444
  37. Giannini EG, Bodini G, Corbo M, Savarino V, Risso D, Di Nolfo MA, et al. Impact of evidence-based medicine on treatment of patients with unresectable hepatocellular carcinoma. Aliment Pharmacol Ther. 2010;31:493–501
  38. Trevisani F, Santi V. Prognostication of the outcome of hepatocellular carcinoma: how to rely on science instead of on the art of Nostradamus. Dig Liver Dis. 2009;41:382–384
  39. Singal A, Volk ML, Waljee A, Salgia R, Higgins P, Rogers MA, et al. Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis. Aliment Pharmacol Ther. 2009;30:37–47

PII: S0168-8278(10)00327-2

doi: 10.1016/j.jhep.2010.03.010

Journal of Hepatology
Volume 53, Issue 2 , Pages 291-297 , August 2010